MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716,126 | +151.2% | 16,440 | +108.4% | 0.18% | +150.7% |
| Q2 2023 | $285,066 | +3.1% | 7,890 | +6.0% | 0.07% | +6.0% |
| Q1 2023 | $276,619 | +49.3% | 7,440 | +81.9% | 0.07% | +48.9% |
| Q4 2022 | $185,318 | -71.8% | 4,090 | -56.5% | 0.04% | -71.2% |
| Q3 2022 | $656,000 | -14.0% | 9,400 | -17.3% | 0.16% | -13.3% |
| Q2 2022 | $763,000 | +121.2% | 11,360 | +170.5% | 0.18% | +45.2% |
| Q1 2022 | $345,000 | -44.0% | 4,200 | 0.0% | 0.12% | -5.3% |
| Q4 2021 | $616,000 | -5.8% | 4,200 | +13.5% | 0.13% | -33.2% |
| Q3 2021 | $654,000 | +990.0% | 3,700 | +900.0% | 0.20% | +1052.9% |
| Q2 2021 | $60,000 | -89.5% | 370 | -88.9% | 0.02% | -91.2% |
| Q1 2021 | $572,000 | -22.1% | 3,340 | 0.0% | 0.19% | -17.8% |
| Q4 2020 | $734,000 | +36.9% | 3,340 | +3.4% | 0.24% | +44.8% |
| Q3 2020 | $536,000 | +21.3% | 3,230 | -43.8% | 0.16% | +1.2% |
| Q1 2020 | $442,000 | +59.6% | 5,750 | +167.4% | 0.16% | +46.4% |
| Q4 2019 | $277,000 | – | 2,150 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |